<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-5951</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-5951</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Новые средства введения инсулина как способ преодоления ?психологической инсулинорезистентности? у больных сахарным диабетом</article-title><trans-title-group xml:lang="en"><trans-title>Novye sredstva vvedeniya insulinakak sposob preodoleniya ?psikhologicheskoy insulinorezistentnosti? u bol'nykh sakharnym diabetom</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестакова</surname><given-names>Марина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakova</surname><given-names>Marina Vladimirovna</given-names></name></name-alternatives><email xlink:type="simple">nephro@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ Эндокринологический научный центр Росмедтехнологий, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2008</year></pub-date><volume>11</volume><issue>1</issue><issue-title>№1 (2008)</issue-title><fpage>77</fpage><lpage>79</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шестакова М.В., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Шестакова М.В.</copyright-holder><copyright-holder xml:lang="en">Shestakova M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/5951">https://www.dia-endojournals.ru/jour/article/view/5951</self-uri><abstract><p>Новые современные технологии играют огромную роль в создании более ?инсулинпозитивного? общества. Благодаря появлению все более удобных шприц-ручек и дозаторов инсулина пациенты меньше боятся этого угрожающего слова ?инсулин?, что отражается и на желании больного контролировать свое заболевание. Врачам необходимо помогать пациентам безболезненно осуществить переход к препаратам инсулина для лучшего контроля гликемии, и новые средства введения инсулина играют в этом не последнюю роль. </p></abstract><kwd-group xml:lang="ru"><kwd>инсулинотерапия</kwd><kwd>сахарный диабет</kwd><kwd>психологический статус</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М.В. Программа по преодолению барьеров в лечении сахарного диабета. По материалам международного исследования DAWN // Сахарный диабет - 2004 -№ 1 -С.50-55</mixed-citation><mixed-citation xml:lang="en">Шестакова М.В. Программа по преодолению барьеров в лечении сахарного диабета. По материалам международного исследования DAWN // Сахарный диабет - 2004 -№ 1 -С.50-55</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Peragallo-Dittko V. Removing barriers to insulin therapy // The Diabetes Educator 2007; 33: 60S-65S</mixed-citation><mixed-citation xml:lang="en">Peragallo-Dittko V. Removing barriers to insulin therapy // The Diabetes Educator 2007; 33: 60S-65S</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Polonsky W.H., Fisher L., Guzman S. et al. Psychological insulin resistance in patients with type 2 diabetes // Diabetes Care 2005; 28: 2543-25-45</mixed-citation><mixed-citation xml:lang="en">Polonsky W.H., Fisher L., Guzman S. et al. Psychological insulin resistance in patients with type 2 diabetes // Diabetes Care 2005; 28: 2543-25-45</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kolaczynski M., Chayer D. NovoPen® 4: percieved as superior in handling and acceptance versus HumaPen Ergo and Optipen Pro by patients and helthcare professionals// Diabetes Technology &amp;amp; Therapeutics, Volume 7, Number 2, 2005, April 7 (2):390</mixed-citation><mixed-citation xml:lang="en">Kolaczynski M., Chayer D. NovoPen® 4: percieved as superior in handling and acceptance versus HumaPen Ergo and Optipen Pro by patients and helthcare professionals// Diabetes Technology &amp;amp; Therapeutics, Volume 7, Number 2, 2005, April 7 (2):390</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Goke B, Gamba S., Erdstieck R.J., et al. NovoPen® 4 offers superior performance, handling and acceptance compared with NovoPen® 3 in insulin-treated diabetes patients // Diabetes Technology &amp;amp; Therapeutics, Volume 7, Number 2, 2005, April 7 (2):379</mixed-citation><mixed-citation xml:lang="en">Goke B, Gamba S., Erdstieck R.J., et al. NovoPen® 4 offers superior performance, handling and acceptance compared with NovoPen® 3 in insulin-treated diabetes patients // Diabetes Technology &amp;amp; Therapeutics, Volume 7, Number 2, 2005, April 7 (2):379</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
